Literature DB >> 9317135

Phenotypic and functional characterization of mice that lack the type I receptor for IL-1.

M B Glaccum1, K L Stocking, K Charrier, J L Smith, C R Willis, C Maliszewski, D J Livingston, J J Peschon, P J Morrissey.   

Abstract

IL-1 alpha and IL-1 beta bind to receptors termed the type I and type II IL-1 receptors. The type I IL-1 receptor is responsible for specific signaling, while the type II IL-1 receptor functions as a nonsignaling decoy receptor. To determine the effect of a defect in IL-1-mediated signaling, mice have been produced with a genetically disrupted type I IL-1 receptor gene. Mice lacking type I IL-1 receptors are of normal vigor and exhibit no overt phenotype. B cells from type I IL-1R-/- mice activated in vitro with anti-IgM do not proliferate in response to IL-1, but do so in response to IL-4. Injection of murine IL-1 alpha does not induce detectable serum IL-6 levels in type I IL-1R-/- mice, but equivalent levels are produced in response to LPS. Type I IL-1R-/- mice have normal serum Ig levels and generate equivalent primary and secondary Ab responses as wild-type mice. In response to LPS, acute phase protein mRNA induction are equivalent in type I IL-1R-/- and wild-type mice. Type I IL-1R-/- mice do not differ from control mice in susceptibility to either a lethal challenge with D-galactosamine plus LPS or high dose LPS. Interestingly, ICE-/-/type I IL-1R-/- double mutant mice are resistant to high dose LPS. Type I IL-1R-/- mice backcrossed to the C57BL/6 background were as equally resistant as wild-type mice to Listeria monocytogenes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317135

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  156 in total

1.  Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages.

Authors:  Helen M Marriott; Kate A Gascoyne; Ravi Gowda; Ian Geary; Martin J H Nicklin; Francesco Iannelli; Gianni Pozzi; Timothy J Mitchell; Moira K B Whyte; Ian Sabroe; David H Dockrell
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

2.  Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase.

Authors:  Jiang Qian; Ling Zhu; Qiming Li; Natalya Belevych; Qun Chen; Fangli Zhao; Scott Herness; Ning Quan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

3.  Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner.

Authors:  Allan Lawrie; Abdul G Hameed; Janet Chamberlain; Nadine Arnold; Aneurin Kennerley; Kay Hopkinson; Josephine Pickworth; David G Kiely; David C Crossman; Sheila E Francis
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

4.  Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection.

Authors:  C P Chen; M Hertzberg; Y Jiang; D T Graves
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.

Authors:  Esen Sefik; Naama Geva-Zatorsky; Sungwhan Oh; Liza Konnikova; David Zemmour; Abigail Manson McGuire; Dalia Burzyn; Adriana Ortiz-Lopez; Mercedes Lobera; Jianfei Yang; Shomir Ghosh; Ashlee Earl; Scott B Snapper; Ray Jupp; Dennis Kasper; Diane Mathis; Christophe Benoist
Journal:  Science       Date:  2015-08-13       Impact factor: 47.728

6.  AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment.

Authors:  Catherine R Lammert; Elizabeth L Frost; Calli E Bellinger; Ashley C Bolte; Celia A McKee; Mariah E Hurt; Matt J Paysour; Hannah E Ennerfelt; John R Lukens
Journal:  Nature       Date:  2020-04-08       Impact factor: 49.962

7.  Tumor-Associated Fatigue in Cancer Patients Develops Independently of IL1 Signaling.

Authors:  Aaron J Grossberg; Elisabeth G Vichaya; Diana L Christian; Jessica M Molkentine; Daniel W Vermeer; Phillip S Gross; Paola D Vermeer; John H Lee; Robert Dantzer
Journal:  Cancer Res       Date:  2017-12-07       Impact factor: 12.701

8.  Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice.

Authors:  Richard A Johnston; Joseph P Mizgerd; Lesley Flynt; Lee J Quinton; Erin S Williams; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

9.  Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells.

Authors:  Dominik Schenten; Simone A Nish; Shuang Yu; Xiting Yan; Heung Kyu Lee; Igor Brodsky; Lesley Pasman; Brian Yordy; F Thomas Wunderlich; Jens C Brüning; Hongyu Zhao; Ruslan Medzhitov
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

10.  Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis.

Authors:  Robert Nason; Jae Y Jung; Richard A Chole
Journal:  J Assoc Res Otolaryngol       Date:  2009-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.